“Diabetes has been consistently associated with increased risk of several of the more common cancers”, and for this reason the American Cancer Society commissions studies on the links and causal relationship between the two diseases which represent the second and seventh most common form of death in the US, according to a recent consensus study on the issue.
For this reason the Julia Ruffin Project is keenly interested in how the papaya leaf affects diabetes, and we want to pay tribute to a study on the long-term anti-diabetic effect of papaya leaves on rats with the disease.
According to the abstract of the study:
Treatment of STZ diabetic rats with C. papaya leaf extract produced significant (P<.05) reductions in FBS from week 2 of treatment. Normoglycaemia was attained in week 8 and sustained till week 24. Significant (P<.05) reductions in serum total cholesterol and LDL-cholesterol concentrations were also observed for most of the points monitored while HDL-cholesterol was significantly (P<.05) increased. The high AI and CRI caused by STZ diabetes was significantly (P<.05) reduced in the C. papaya treated diabetic rats.
The findings from this study substantiate the long term potential and traditional usage of C. papaya for antidiabetic and antihyperlipidaemic effects.
–Long Term Anti-Diabetic, Anti-Hyperlipidaemic and Anti-Atherogenic Effects of Carica papaya Leaves in Streptozotocin Diabetic Rats
Omonkhua Akhere A.1*, Onoagbe Iyere O.2, Ajileye Afolabi F.3, Aladegboye Lekan O.3 and Adetoboye Ayodeji R
European Journal of Medicinal Plants 3(4): 508-519, 2013